Doctors told Healthline and Fox News Digital the symptom can mean fishy burps or halitosis, but it is not listed for Ozempic, Wegovy, Mounjaro or Zepbound.
There is no peer-reviewed evidence confirming a causal link or mechanism, though physicians said dehydration, reflux and gut flora changes could contribute and advised hydration, probiotics, protein and fiber.
Social media users described persistent bad breath and sulfur burps, while Hershey's chief executive said rising GLP-1 use has boosted gum and mint purchases.
Could 'Ozempic breath' and dental issues signal deeper, overlooked risks for millions using GLP-1 drugs as they become more affordable and widespread?
How might food and dental industries adapt as more people experience unlisted GLP-1 side effects and change their habits?
With GLP-1 drugs reshaping diets and industries, are current safety monitoring and patient guidance enough to catch hidden long-term side effects?